The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
I’m living in Australia at the moment and what I will say is, apart from hot copper, I can’t find a single bad word being said about this company anywhere on the internet.
I’ve no idea where this share will go in the future but there’s nothing out to suggest this isn’t a normal pharma company.
Just google the name.
I’m in the same boat. Not worth selling now. Let’s hope we get some real news to arrest this fall. It’s like Groundhog Day.
I wonder whether yesterday’s mess of the Beckham share has put people off this sector a little for now?
Maybe we need the backing of a famous footballer?
I’ll email the company and see if they can stick Peter Beardsley’s face on the box. Then we’ll rocket.......maybe
Finally gave in and topped up. I’m hoping this is the bottom. Got my average down to 5.56. Tide has to turn sometime.
ASX finished the UK equivalent of 4.55p :(
Yeah, I’m hoping for resistance at 5p. I’d love a blue day today.
And into the 4’s we go. I should just switch off but can’t help watching.
Finished down 17.1% in Aus @ 8.7c.
Equal to 4.86p
Yeah, wait until the Yanks pile in later. That’ll sort it.
(I’m kidding).
Tbh, I think we’ll all do ok here. It’s only priced at 5.55 at the moment and it’s already proved how fast it can move up when it wants. I don’t know about anybody else but this has happened to me loads of times and I’ve nearly always regretted bailing out.
That’s because the mms don’t need any more to sell at the moment. Usually happens when a lot of people are all trying to sell. I’ll stick my head in the sand and hope for the best. One good rns and back up it’ll go.
Pretty much the same as me Hodl. I’m just holding now and see what happens in the future. I’m not selling and losing again. As soon as I do, there’ll be a great rns. It always happens to me.
All the ‘just topped up’ brigade have moved on.
I’m crap at picking the days winners so I’ll hold and hope for the best.
Gla
Closed up at 10.5c
To clarify. Australia’s 4pm Friday close is at 7am Friday UK time.
Australia closed :
Asx 12.5¢ Change 0.030(31.6%)
Chi-X 12.5¢ Change 0.030 ( 41.2
Friday close of business here is before UK close of business so Australia follow the UK.
It’ll probably go up 50% on Monday. No doubt somebody will take it seriously and go for it.
Totally agree about people with large followings affecting penny stocks. I remember Chris Oil pumping socks he was invested in, only to to sell out and leave punters spiked.
While things are quiet on the board, I thought it was interesting to read this broker view from 8 years ago.
Interesting to see how things looked back then.
This was around the time of my first purchase here.
Tissue Regenix's takeover value may eventually top US$1bn suggests broker
2013-12-05 10:56:00
A long way to go, says Jefferies, but launch of skin replacement product next year will highlight the potential.
Medtech group Tissue Regenix (LON:TRX) could be worth more than US$1bn if all of its product areas take off, a punchy note from US broker Jefferies has suggested.
The launch soon of its first product, a wound care treatment, could see the shares double in value as the story de-risks and first sales are generated, the house suggested.
“Eventually, if the products deliver on their promising early results, we would expect interest from the global medtech companies, and if each product area works, we see the potential for Tissue to be a US$1bn company.”
Tissue Regenix’s technology can be used to replace human body parts and addresses markets that today are valued at more than US$10bn, it said.
Its proprietary method of washing human and animal tissue has shown very promising results in small data sets, and Jefferies suggests there is significant upside from a successful launch of its skin replacement for wounds.
"The trial results and initial sales over the next 12-24 months could see Tissue Regenix become a takeover target," it said. The large medical device companies are grappling with how to move beyond metal and plastic implants, and the company can deliver a neat affordable solution.
As well as wound care, Tissue Regenix is developing products for meniscus and ligament repair and heart valve replacements, among others.
In heart valves, for example, Tissue has eight years of clinical data from Brazil and it has proved so superior to alternatives one tissue bank is now only using its process
Companies with products addressing similar needs have fetched valuations of US$500-700mln. Tissue Regenix has several product areas and so will get several shots at goal, Jefferies adds.
Based on historical takeover valuations, all of these areas combined could be worth "north of US$1.5bn or about 10 times the current share price in a break-up and take-out scenario".
On a cash flow analysis, the broker has a target price of 29p per share and is a buyer.
Shares rose to 15.05p today.